SCHEMBL24666254

SCHEMBL24666254

Cc1ccncc1-c1cc2cnc(NC(=O)C3CC3)cc2n(CC2CC2)c1=O

nearest known ligand 0.58

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
▸ ABL1 P00519 15/20 0.58
▸ MAP4K1 Q92918 5/20 0.54

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24664999 0.91 ABL1 (0.61) ABL1MAP4K1
SCHEMBL24665005 0.91 ABL1 (0.61) ABL1MAP4K1
SCHEMBL24664995 0.91 ABL1 (0.61) ABL1MAP4K1
SCHEMBL24664996 0.91 ABL1 (0.61) ABL1MAP4K1
SCHEMBL24666436 0.91 ABL1 (0.60) ABL1MAP4K1
SCHEMBL24664961 0.86 ABL1 (0.63) ABL1MAP4K1
SCHEMBL24666565 0.84 ABL1 (0.52) ABL1MAP4K1
SCHEMBL24666562 0.84 ABL1 (0.52) ABL1MAP4K1
SCHEMBL29977729 0.82 ABL1 (0.45) ABL1MAP4K1
SCHEMBL24666973 0.81 ABL1 (0.64) ABL1MAP4K1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2022236319-A1 NAPHTHYRIDONE COMPOUNDS FOR INHIBITION OF RAF KINASES AND/OR BCR-ABL TYROSINE KINASES ENLIVEN THERAPEUTICS, INC. (US) 2022-11-10 — — WO disclosed
Send feedback